Skip to content

Breathing Exercises Versus Incentive Spirometry in Third-Trimester Pregnancy

Comparative Effects of Deep Breathing Exercises and Volume-oriented Incentive Spirometry on Dyspnea, Functional Endurance, and Pulmonary Function During the Third Trimester of Pregnancy

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07365163
Enrollment
36
Registered
2026-01-26
Start date
2025-04-05
Completion date
2025-08-08
Last updated
2026-01-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyspnea During Pregnancy, Physiological Changes in Pregnancy, Reduced Functional Endurance

Keywords

Physical Therapy, Deep Breathing Exercises, Incentive Spirometry, Pregnancy, Third Trimester, Dyspnea

Brief summary

Shortness of breath (dyspnea) is commonly experienced during the third trimester of pregnancy due to physiological changes affecting the respiratory system. Non-pharmacological breathing interventions are often recommended to improve breathing comfort and functional capacity in pregnant women. This randomized controlled trial compared the effects of deep breathing exercises and volume-oriented incentive spirometry on dyspnea, functional endurance, and pulmonary function in women during the third trimester of pregnancy. Eligible participants were randomly assigned to one of two intervention groups. One group performed supervised deep breathing exercises, while the other group performed volume-oriented incentive spirometry exercises. Outcomes were measured before and after the intervention period and included the severity of dyspnea, functional endurance, and pulmonary function parameters. The results of this study aim to provide evidence regarding the effectiveness of simple, safe, and non-invasive breathing interventions for improving respiratory outcomes during late pregnancy.

Detailed description

This study was a randomized controlled trial designed to evaluate and compare the effects of two non-pharmacological respiratory interventions in women during the third trimester of pregnancy. Physiological changes during pregnancy, such as diaphragmatic elevation and increased oxygen demand, can contribute to dyspnea and reduced functional endurance. Safe and effective breathing interventions may help alleviate these symptoms without pharmacological risk. Eligible pregnant women in their third trimester who met the inclusion criteria were recruited and randomly allocated into two intervention groups using a randomization method. Participants in Group A received a structured deep breathing exercise program, which focused on slow, controlled inhalation and exhalation techniques performed under supervision. Participants in Group B received volume-oriented incentive spirometry training, which encouraged sustained maximal inspiration using a standard incentive spirometer device. Both interventions were administered according to a predefined protocol over the study period. Outcome measures were assessed at baseline and after completion of the intervention period. Primary outcomes included the assessment of dyspnea severity. Secondary outcomes included measures of functional endurance and pulmonary function. The study was conducted in accordance with ethical standards and received approval from the institutional ethics review committee. All participants provided informed consent prior to participation. The findings of this study are intended to contribute to evidence-based physical therapy practice by identifying effective, low-risk breathing interventions for managing dyspnea and improving respiratory function during the third trimester of pregnancy.

Interventions

Deep breathing exercises focused on diaphragmatic breathing with slow, deep inhalation followed by controlled exhalation. The exercises were performed according to a standardized protocol under supervision.

Volume-oriented incentive spirometry involved slow, sustained maximal inspiration using an incentive spirometer device to encourage lung expansion and improve respiratory function, performed under supervision according to protocol.

Sponsors

University of Lahore
Lead SponsorOTHER
University of Lahore Hospital (ULH)
CollaboratorNETWORK

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessors were blinded to group allocation to reduce assessment bias. Participants and care providers were not blinded due to the nature of the interventions.

Intervention model description

Participants were randomly assigned to one of two parallel intervention groups: a deep breathing exercise group or a volume-oriented incentive spirometry group.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* \- Participants aged between 18 and 40 years * Blood pressure below 140/90 mmHg * Not pregnant * Primigravida women * Participants in the third trimester of pregnancy * Able to understand and follow instructions * Willing to participate and provide informed consent

Exclusion criteria

* \- History of cardiovascular disorders * History of respiratory disorders * History of psychological disorders * History of medical or surgical conditions involving the nose, throat, diaphragm, or lungs * Any condition that could interfere with participation in breathing exercises or spirometry

Design outcomes

Primary

MeasureTime frameDescription
Functional EnduranceBaseline and at the end of the intervention period (approximately 6 weeks)Functional endurance was assessed using the 6-Minute Walk Test (6MWT), which measures the total distance walked by a participant on a flat surface over six minutes. The outcome is reported in meters, with higher values indicating better functional endurance. The minimum possible value is 0 meters, and there is no predefined maximum value.

Secondary

MeasureTime frameDescription
Forced Expiratory Volume in One Second (FEV₁)Baseline and at the end of the intervention period (approximately 6 weeks)Pulmonary function was assessed using spirometry by measuring Forced Expiratory Volume in one second (FEV₁). FEV₁ is reported in liters, with higher values indicating better pulmonary function.
Forced Vital Capacity (FVC)Baseline and at the end of the intervention period (approximately 6 weeks)Pulmonary function was assessed using spirometry by measuring Forced Vital Capacity (FVC). FVC is reported in liters, with higher values indicating better pulmonary function.

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026